These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2129065)

  • 21. Effectiveness of netilmicin and tobramycin against Pseudomonas aeruginosa in vitro and in an experimental tissue infection in mice.
    Moffie BG; Hoogeterp JJ; Lim T; Douwes-Idema AE; Mattie H
    J Antimicrob Chemother; 1993 Mar; 31(3):403-11. PubMed ID: 8486574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of erythromycin and clindamycin in an experimental Staphylococcus aureus infection in normal and granulocytopenic mice. A comparative in vivo and in vitro study.
    Hoogeterp JJ; Mattie H; van Furth R
    Scand J Infect Dis; 1993; 25(1):123-32. PubMed ID: 8460336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperbranched poly(NIPAM) polymers modified with antibiotics for the reduction of bacterial burden in infected human tissue engineered skin.
    Shepherd J; Sarker P; Rimmer S; Swanson L; MacNeil S; Douglas I
    Biomaterials; 2011 Jan; 32(1):258-67. PubMed ID: 20933276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic effects of subinhibitory antibiotic concentrations.
    Tornqvist IO; Holm SE; Cars O
    Scand J Infect Dis Suppl; 1990; 74():94-101. PubMed ID: 2097721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the anti-infectious properties of polyester vascular prostheses functionalised with cyclodextrin.
    Jean-Baptiste E; Blanchemain N; Neut C; Chai F; Maton M; Martel B; Hildebrand H; Haulon S
    J Infect; 2014 Feb; 68(2):116-24. PubMed ID: 24140067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.
    Hoogeterp JJ; Mattie H; Krul AM; Terporten P; van Furth R
    Scand J Infect Dis; 1989; 21(1):95-101. PubMed ID: 2727631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of rifampicin against Staphylococcus aureus in vitro and in an experimental infection in normal and granulocytopenic mice.
    Hoogeterp JJ; Mattie H; Krul AM; van Furth R
    Scand J Infect Dis; 1988; 20(6):649-56. PubMed ID: 2975827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.
    Calame W; Guiot HF; Mattie H
    Scand J Infect Dis; 1990; 22(6):717-23. PubMed ID: 2149467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives.
    Hardy DJ; Swanson RN; Shipkowitz NL; Freiberg LA; Lartey PA; Clement JJ
    Antimicrob Agents Chemother; 1991 May; 35(5):922-8. PubMed ID: 1854173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.
    Vogelman B; Gudmundsson S; Leggett J; Turnidge J; Ebert S; Craig WA
    J Infect Dis; 1988 Oct; 158(4):831-47. PubMed ID: 3139779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.
    Mattie H; Zhang LC; van Strijen E; Sekh BR; Douwes-Idema AE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2083-8. PubMed ID: 9333029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nonspecific defenses by soil infection potentiating factors.
    Haury BB; Rodeheaver GT; Pettry D; Edgerton MT; Edlich RF
    Surg Gynecol Obstet; 1977 Jan; 144(1):19-24. PubMed ID: 401548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together.
    Standiford HC; Viollier AF; Moody M; Klastersky J; Tatem B; Schimpff SC
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():47-9. PubMed ID: 6210682
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity.
    Godin B; Touitou E
    Curr Drug Deliv; 2005 Jul; 2(3):269-75. PubMed ID: 16305429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of polymethylmethacrylate and antibiotic combinations on bacterial viability. An in vitro and preliminary in vivo study.
    Chapman MW; Hadley WK
    J Bone Joint Surg Am; 1976 Jan; 58(1):76-81. PubMed ID: 765348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro pharmacodynamic models to determine the effect of antibacterial drugs.
    Gloede J; Scheerans C; Derendorf H; Kloft C
    J Antimicrob Chemother; 2010 Feb; 65(2):186-201. PubMed ID: 20026612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftobiprole: Farewell or just a delay?
    Chahine EB
    Am J Health Syst Pharm; 2010 Jun; 67(12):981. PubMed ID: 20516467
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicting the clinical efficacy of antibiotics: toward definitive criteria.
    Scaglione F
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S56-9. PubMed ID: 9076837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.
    Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():149-58. PubMed ID: 8335516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.